PURE Bioscience, Inc. (PURE)

PURE Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is August - July.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Net Income	-2.21	-2.4	-3.35	-3.96	-3.49	-2.32
Depreciation & Amortization	0	0	0.15	0.12	0.21	0.17
Asset Writedown & Restructuring Costs	-	-	0.06	0.32	0.35	-
Stock-Based Compensation	0.18	0.15	0.21	0.32	0.57	0.84
Other Operating Activities	-	-	-	0.03	-0.16	0.15
Change in Accounts Receivable	0.05	-0.18	-0.01	-0.08	0.17	0.72
Change in Inventory	-0.1	-0.09	0.03	0.06	0.08	0.07
Change in Accounts Payable	-0.07	0.21	0.2	-0.04	-0.16	-0.78
Change in Other Net Operating Assets	0.37	0.29	0.18	-0.04	0.01	-0.02
Operating Cash Flow	-1.78	-2.02	-2.53	-3.28	-2.42	-1.17
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Capital Expenditures	-	-	-	-0.03	-0.08	-0.52
Investing Cash Flow	-	-	-	-0.03	-0.08	-0.52

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Long-Term Debt Issued	-	2	1.79	1.02	-	0.24
Total Debt Issued	1.22	2	1.79	1.02	-	0.24
Net Debt Issued (Repaid)	1.22	2	1.79	1.02	-	0.24
Issuance of Common Stock	1	-	-	-	3.5	-
Financing Cash Flow	2.22	2	1.79	1.02	3.5	0.24

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Net Cash Flow	0.44	-0.02	-0.75	-2.3	1	-1.45

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Free Cash Flow	-1.78	-2.02	-2.53	-3.31	-2.5	-1.69
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	-73.49%	-91.51%	-128.94%	-176.40%	-134.86%	-42.98%
Free Cash Flow Per Share	-0.02	-0.02	-0.02	-0.03	-0.03	-0.02
Levered Free Cash Flow	-1.39	-1.51	-1.44	-1.95	-1.23	-0.82
Unlevered Free Cash Flow	-1.15	-1.32	-1.34	-1.94	-1.23	-0.81

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Cash Income Tax Paid	0	0	0.01	0.01	0	0
Change in Working Capital	0.25	0.24	0.4	-0.11	0.1	-0.01

Data Source: S&P Global Market Intelligence Last updated: Jun 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error